Catheter ablation for atrial fibrillation on uninterrupted warfarin: Can it be done without echo guidance?

Journal of Cardiovascular Electrophysiology

Volumn 22, Issue 3, 2011, Pages 265-270

  Page, Stephen P ^a   Siddiqui, M Shoaib ^a   Finlay, Malcolm ^a   Hunter, Ross J ^a   Abrams, Dominic J ^a   Dhinoja, Mehul ^a   Earley, Mark J ^a   Sporton, Simon C ^a   Schilling, Richard J ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

atrial fibrillation; bleeding; catheter ablation; intracardiac echocardiography; tamponade; warfarin

Indexed keywords

ENOXAPARIN; VITAMIN K GROUP; WARFARIN;

ADULT; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; BLOOD TRANSFUSION; CATHETER ABLATION; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DRUG COST; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART TAMPONADE; HEMATOMA; HUMAN; INJECTION SITE PAIN; INTERNATIONAL NORMALIZED RATIO; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PERICARDIAL EFFUSION; PERICARDIOCENTESIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SIDE EFFECT; STROKE; VASCULAR ACCESS;

ANTICOAGULANTS; ATRIAL FIBRILLATION; CATHETER ABLATION; CHI-SQUARE DISTRIBUTION; COST-BENEFIT ANALYSIS; DRUG ADMINISTRATION SCHEDULE; DRUG COSTS; ECHOCARDIOGRAPHY; FEMALE; HEMORRHAGE; HEPARIN, LOW-MOLECULAR-WEIGHT; HOSPITAL COSTS; HUMANS; INTERNATIONAL NORMALIZED RATIO; LONDON; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; WARFARIN;

EID: 79952501316     PISSN: 10453873     EISSN: 15408167     Source Type: Journal    
DOI: 10.1111/j.1540-8167.2010.01910.x     Document Type: Article

References (19)

1. Calkins H, Brugada J, Packer DL, Cappato R, Chen SA, Crijns HJ, Damiano RJ Jr, Davies DW, Haines DE, Haissaguerre M, Iesaka Y, Jackman W, Jais P, Kottkamp H, Kuck KH, Lindsay BD, Marchlinski FE, McCarthy PM, Mont JL, Morady F, Nademanee K, Natale A, Pappone C, Prystowsky E, Raviele A, Ruskin JN, Shemin RJ,: HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: Recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. Developed in partnership with the European Heart Rhythm Association (EHRA). Heart Rhythm 2007; 4: 816-861. (Pubitemid 46850611)
2. Naccarelli GV, Johnston SS, Lin J, Patel PP, Schulman KL,: Cost burden of cardiovascular hospitalization and mortality in ATHENA-like patients with atrial fibrillation/atrial flutter in the United States. Clin Cardiol 2010; 33: 270-279.
3. Kok LC, Mangrum JM, Haines DE, Mounsey JP,: Cerebrovascular complication associated with pulmonary vein ablation. J Cardiovasc Electrophysiol 2002; 13: 764-767. (Pubitemid 34921134)
4. Oral H, Chugh A, Ozaydin M, Good E, Fortino J, Sankaran S, Reich S, Igic P, Elmouchi D, Tschopp D, Wimmer A, Dey S, Crawford T, Pelosi F Jr, Jongnarangsin K, Bogun F, Morady F,: Risk of thromboembolic events after percutaneous left atrial radiofrequency ablation of atrial fibrillation. Circulation 2006; 114: 759-765. (Pubitemid 44268226)
5. Cheema A, Dong J, Dalal D, Vasamreddy CR, Marine JE, Henrikson CA, Spragg D, Cheng A, Nazarian S, Sinha S, Halperin H, Berger R, Calkins H,: Long-term safety and efficacy of circumferential ablation with pulmonary vein isolation. J Cardiovasc Electrophysiol 2006; 17: 1080-1085. (Pubitemid 44401567)
6. Bunch TJ, Asirvatham SJ, Friedman PA, Monahan KH, Munger TM, Rea RF, Sinak LJ, Packer DL,: Outcomes after cardiac perforation during radiofrequency ablation of the atrium. J Cardiovasc Electrophysiol 2005; 16: 1172-1179.
7. Hsu LF, Jaïs P, Hocini M, Sanders P, Scavée C, Sacher F, Takahashi Y, Rotter M, Pasquie JL, Clémenty J, Haïssaguerre M,: Incidence and prevention of cardiac tamponade complicating ablation for atrial fibrillation. Pacing Clin Electrophysiol 2005; 28 (Suppl 1): S106-S109. (Pubitemid 40171095)
8. Cappato R, Calkins H, Chen SA, Davies W, Iesaka Y, Kalman J, Kim YH, Klein G, Natale A, Packer D, Skanes A, Ambrogi F, Biganzoli E,: Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circ Arrhythm Electrophysiol 2010; 3: 32-38
9. Prudente LA, Moorman JR, Lake D, Xiao Y, Greebaum H, Mangrum JM, DiMarco JP, Ferguson JD,: Femoral vascular complications following catheter ablation of atrial fibrillation. J Interv Card Electrophysiol 2009; 26: 59-64.
10. Schmidt M, Segerson NM, Marschang H, Akoum N, Rittger H, Clifford SM, Brachmann J, Daccarett M, Marrouche NF,: Atrial fibrillation ablation in patients with therapeutic international normalized ratios. Pacing Clin Electrophysiol 2009; 32: 995-999.
11. Wazni OM, Beheiry S, Fahmy T, Barrett C, Hao S, Patel D, Di Biase L, Martin DO, Kanj M, Arruda M, Cummings J, Schweikert R, Saliba W, Natale A,: Atrial fibrillation ablation in patients with therapeutic international normalized ratio: Comparison of strategies of anticoagulation management in the periprocedural period. Circulation 2007; 116: 2531-2534. (Pubitemid 350179218)
12. Hussein AA, Martin DO, Saliba W, Patel D, Karim S, Batal O, Banna M, Williams-Andrews M, Sherman M, Kanj M, Bhargava M, Dresing T, Callahan T, Tchou P, Di Biase L, Beheiry S, Lindsay B, Natale A, Wazni O,: Radiofrequency ablation of atrial fibrillation under therapeutic international normalized ratio: A safe and efficacious periprocedural anticoagulation strategy. Heart Rhythm 2009; 6: 1425-1429.
13. Di Biase L, Burkhardt JD, Mohanty P, Sanchez J, Horton R, Gallinghouse GJ, Lakkireddy D, Verma A, Khaykin Y, Hongo R, Hao S, Beheiry S, Pelargonio G, Dello Russo A, Casella M, Santarelli P, Santangeli P, Wang P, Al-Ahmad A, Patel D, Themistoclakis S, Bonso A, Rossillo A, Corrado A, Raviele A, Cummings JE, Schweikert RA, Lewis WR, Natale A,: Periprocedural stroke and management of major bleeding complications in patients undergoing catheter ablation of atrial fibrillation. The impact of periprocedural therapeutic international normalized ratio. Circulation 2010; 121: 2550-2556.
14. Perry RJ, Moore CA, Morgan BD, Plummer DL,: Determining the approximate area of a burn: An inconsistency investigated and re-evaluated. Br Med J 1996; 312: 1338. (Pubitemid 26158307)
15. Chilukuri K, Sinha S, Berger R, Marine JE, Cheng A, Nazarian S, Scherr D, Spragg D, Calkins H, Henrikson CA,: Association of transseptal punctures with isolated migraine aura in patients undergoing catheter ablation of cardiac arrhythmias. J Cardiovasc Electrophysiol 2009; 20: 1227-1230
16. Kwak JJ, Pak HN, Jang JK, Kim SK, Park JH, Choi JI, Hwang C, Kim YH,: Safety and convenience of continuous warfarin strategy during the periprocedural period in patients who underwent catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol 2010; 21: 620-625
17. Muntwyler J, Attenhofer Jost CH, Diefenbacher W, Beer JH, Nikolic R, Amanpour F, Faeh-Gunz A, Naegeli B, Straumann EH, Maurer D, Candinas R, Dang L, Scharf C,: Interaction of vitamin K antagonists with heparin affect monitoring by activated clotting times. J Interv Card Electrophysiol 2010; 27: 89-94
18. Full prescibing information for Lovenox® (enoxaparin sodium injection) for subcutaneous and intravenous use. sanofi-aventis U.S. LLC, 2008.
19. Octapharma: Octaplex® Human Prothrombin Complex Product Monograph. 2007.